Newcomer Mark sold $767K of PAYS

Newcomer Mark (CEO) sold 50,000 shares of Paysign, Inc. (PAYS) at $15.34 ($0.77M total) on 2026-10-09 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Newcomer Mark
Published Oct 15, 2026, 1:00 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 15, 2026, 1:02 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$PAYS
Neutral
medium confidence
Mentioned
$PAYS
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$PAYSNeutralLow
01

Why it matters

The transaction provides fresh primary data on insider activity, useful for short‑term sentiment assessment.

02

Market read

Insider sell by the CEO may create slight downward pressure; traders should monitor for further insider activity.

03

What to watch

Potential upcoming corporate actions or financing needs not disclosed.

Relevance 4/10Novelty 4/10Timing: after-hours filing

Background

Form 4 filing from SEC EDGAR discloses an insider transaction by the CEO of Paysign, Inc.

Company-level read

Ticker impact

$PAYSNeutralMedium confidence
Context

CEO Newcomer Mark sold 50,000 shares for $766,895 via a 10b5-1 plan, reducing his stake to 9,113,002 shares.

Expected impact

likely pressure as the market prices in the insider sell

Evidence & confidence

The sale is modest in size (< $1M) but involves the CEO, which can influence short-term sentiment.

Market effects

Minimal impact on the broader payments sector.

Limited to US markets where Paysign trades.

Low global relevance.

Counterpoint

The sale could be routine under a pre‑arranged plan and not indicate negative sentiment.

Key entities

  • Paysign, Inc.

    US‑listed payments processor (ticker PAYS).

  • Newcomer Mark

    CEO and 10% owner of Paysign.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$PAYSMedAI 8/10

Paysign (PAYS) Q3 2026 Earnings Call Transcript

Paysign (PAYS) reported Q3 2026 earnings, highlighting growth in its patient affordability business with revenue doubling to $16.6M YoY. Plasma revenue rose 7.5% to $13.8M. The company expects to offset a loss of 113 plasma centers with new clients. Patient affordability drove strong margins and operating leverage, while Apherion, a plasma industry software, is under regulatory review.

$PAYSHigh

Paysign Reports Record Third Quarter 2026 Revenue of $30.8 Million, Up 43%; Operating Margin More Than Triples to 23.8%

Paysign, Inc. (PAYS) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Earnings Release Paysign Reports Record Third Quarter 2026 Revenue of $30.8 Million, Up 43%; Operating Margin More Than Triples to 23.8% Patient Affordability Growth Drives Revenue and Margin Expansion Raises Full Year 2026 Gross Margin, Net Income, GAAP EPS and Adju

$PAYSHigh

Paysign Reports Record Second Quarter 2026 Revenue of $28.3 Million, Up 48%; Raises Full-Year Outlook

Paysign, Inc. (PAYS) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Earnings Release Paysign Reports Record Second Quarter 2026 Revenue of $28.3 Million, Up 48%; Raises Full-Year Outlook Growth Driven by Continued Momentum in Plasma and Patient Affordability Businesses Mix Shift and Expense Discipline Continue to Drive Gross and Oper